Proton Radiation Therapy
Proton Radiation Therapy is a medical device with 12 clinical trials. Currently 2 active trials ongoing. Historical success rate of 77.8%.
Success Metrics
Based on 7 completed trials
Phase Distribution
Phase Distribution
3
Early Stage
1
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
77.8%
7 of 9 finished
22.2%
2 ended early
2
trials recruiting
12
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Proton Therapy for Recurrent Nasopharyngeal Carcinoma
Varian ProBeam360° Proton Therapy System China Clinical Trial (Wuhan)
Folfox+Irinotecan+Chemort In Esophageal Cancer
Proton Beam Teletherapy for Post-Hysterectomy Cancers of the Uterus and Cervix
Study on the Safety and Effectiveness of Varian ProBeam Proton Therapy Equipment in the Treatment of Solid Tumors
Clinical Trials (12)
Proton Therapy for Recurrent Nasopharyngeal Carcinoma
Varian ProBeam360° Proton Therapy System China Clinical Trial (Wuhan)
Folfox+Irinotecan+Chemort In Esophageal Cancer
Proton Beam Teletherapy for Post-Hysterectomy Cancers of the Uterus and Cervix
Study on the Safety and Effectiveness of Varian ProBeam Proton Therapy Equipment in the Treatment of Solid Tumors
Proton Therapy for Early Stage Breast Cancer
Intensity-Modulated or Proton Radiation Therapy for Sinonasal Malignancy
Proton Radiotherapy for Stage I, IIA, and IIB Seminoma
Late Effects of Proton Radiation Therapy in Patients With Low-Grade Glioma
Chemotherapy and Proton Radiation for the Treatment of Locally Advanced Lung Cancer
Proton Beam Therapy for Treatment of Hepatocellular Carcinoma
Proton Therapy and Bevacizumab for Primary Liver Tumors
All 12 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 12